🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the pharmacokinetics of belapectin in subjects with ...
Status
Completed
Location
Inland Empire Clinical Trials
Start Date
2020-06-16
Trial ID
NCT04332432
Treatments Being Tested
The primary objective of this study is to characterize the safety, tolerabi...
Status
Completed
Location
Brooke Army Medical Ctr.
Start Date
2013-07
Trial ID
NCT01899859
A Randomized, Controlled, Double-blind, Parallel Group, Single Center Phase...
Status
Completed
Location
Brooke Army Medical Center
Start Date
2015-09
Trial ID
NCT02421094
This study is a dose escalation of GR-MD-02 with the standard therapeutic d...
Status
Completed
Location
Providence Cancer Center
Start Date
2016-05-16
Trial ID
NCT02575404
Treatments Being Tested
The purpose of this study is to test the safety \& efficacy of combination ...
Status
Withdrawn
Location
Portland Providence Medical Center
Start Date
2023-07-01
Trial ID
NCT04987996
Treatments Being Tested
Study GT-030 is a phase 2a, single-center, open-label study of subjects wit...
Status
Completed
Location
Brooke Army Medical Ctr.
Start Date
2015-09
Trial ID
NCT02407041
Treatments Being Tested
The goal of this study is to determine a safe dose of GR-MD-02 used in comb...
Status
Completed
Location
Providence Portland Medical Center
Start Date
2014-05-08
Trial ID
NCT02117362
Treatments Being Tested
Study GT 026 is a Phase 2, multicenter, parallel group, North American, ran...
Status
Completed
Location
Cedars Sinai Medical Center
Start Date
2015-06
Trial ID
NCT02462967
This seamless, adaptive, two-stage, Phase 2b/3, randomized, double-blind, m...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2020-06-25
Trial ID
NCT04365868
Treatments Being Tested